Funded Tech Companies

Aukera Therapeutics

Aukera Therapeutics, based in Basel, received investment capital from Kick Start Sales Force, Zürcher Kantonalbank and private investors.

Company Overview

Company Name
Aukera Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Spitalstrasse 41
Basel, 4056
Switzerland
Phone
Undisclosed
Email Address

Company Background Information

Overview
Aukera Therapeutics is a preclinical-stage biotech spin-off from the Biozentrum of the University of Basel. We develop the first RAPTOR inhibitors for the treatment of mTORC1-related pathologies. We combine mTOR expertise with an AI-driven drug discovery engine built for complex and hard-to-drug targets.
Profile
Aukera Therapeutics LinkedIn Company Profile
Social Media
Aukera Therapeutics Company Twitter Account
Company News
Aukera Therapeutics News
Facebook
Aukera Therapeutics on Facebook
YouTube
Aukera Therapeutics on YouTube
Last Transaction
12/11/2025

Financing History

Date
Type
Amount
Venture Equity
$5,700,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Stefan Imseng
  Stefan Imseng LinkedIn Profile  Stefan Imseng Twitter Account  Stefan Imseng News  Stefan Imseng on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

AUI | Aulos Bioscience

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary